Consulting Wallah › Market Intelligence › Oman healthcare market
Market Intelligence · Hospitals & healthcare services

Oman healthcare market: size, growth and outlook 2026–2032

Opening to private investment and mandatory insurance; strong Indian-group presence. Sized from published research with a GCC and India lens, for buyers, suppliers and investors.

Published 03 Nov 2026Updated 03 Nov 2026Forecast 2026–2032Base year 2025Report code CW-MI-OMA
2025 market (CW estimate)USD 4.9 bnpublished range USD 4.7 bn–USD 5.1 bn
2032 (CW estimate)USD 7.4 bncentral case, ~6% CAGR
Published CAGR range4.05–7.5%across sources

Executive summary

Opening to private investment and mandatory insurance; strong Indian-group presence. Published estimates normalised to 2025 range from USD 4.7 bn to USD 5.1 bn; the Consulting Wallah central estimate is USD 4.9 bn, growing at about 6% a year to USD 7.4 bn by 2032. Scope differences between publishers explain most of the spread — the comparison table below states each one.

Growth is driven by roll-out of mandatory health insurance (Dhamani platform; e-claims and e-eligibility mandated); government infrastructure investment: ~RO 1 bn MoH budget 2026; 9 new hospitals adding 1,660+ beds; rising NCD burden: 60%+ adults overweight/obese, ~33% hypertensive, 17% adult diabetes prevalence (IDF 2024).

Context that matters for buyers and suppliers: Oman had 92 hospitals and 7,691 beds per the MoH annual report cited by Nexdigm (2025). Healthcare facilities rose 50% from 1,592 (2020) to 2,384 (2024); private clinics are 51% of facilities. Nizwa Hospital expansion (RO 30 mn) adds 245 beds to 555; Sohar Hospital expansion (RO 28 mn) to 636+ beds. Dhamani platform mandates e-claims and e-eligibility; regulations issued via circular 6521 and Decision E/131/2022.

Market size and forecast

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 4.7 bn–USD 5.1 bn; differences are mostly scope.

8.36.24.12.10.04.3620234.6220244.920255.1920265.5120275.8420286.1920296.5620306.9520317.372032USD billion · dark = reported/historical · orange = estimate · light orange = forecast
Oman healthcare market, USD bn. Dark bars reconstructed from the central estimate; 2025 onward Consulting Wallah estimate. Sources listed below.

How published estimates compare

Publisher (date)Base valueForecastCAGR
Nexdigm (2025-07) — country - Oman healthcare market (hospitals, outpatient, payUSD 4.4 bn (2024)— (2030)7.5% (2025-2030)
MarkNtel Advisors (2026-03) — country - Oman healthcare market (expenditure, pharma, devicUSD 5.10 bn (2026E: USD 5.31 bn) (2025)USD 6.74 bn (2032)4.05% (2026-2032)
Oman Ministry of Health (via Oman Observer) (2026-02) — country - public health budget (Ministry of Health only), noRO 1 bn (~USD 2.6 bn) MoH 2026 budget (2026)— ()—
Consulting Wallah central estimateUSD 4.9 bn (2025)USD 7.4 bn (2032)~6%

Source: Publisher pages as listed under Sources; CW estimate as described in Method.

Scope and definitions

Included: public and private hospital, clinic, diagnostic and long-term care services and the associated health expenditure. Excluded: pharmaceutical and device product sales, insurance premiums and health IT (covered in separate reports). Published totals differ mainly by whether products and insurance are folded in.

Segmentation analysis

Shares as reported by the named sources; ranking is more reliable than the exact percentage.

Care setting / payor (qualitative)

SegmentShareNote
Private clinics51%
2025 health statistics cited by Oman Observer, Feb 2026

Source: Nexdigm Jul 2025; Oman Observer Feb 2026

Therapeutic area (patient burden)

SegmentShareNote
Diabetes15%
largest therapeutic segment per MarkNtel
Cardiovascular10%
MarkNtel

Source: MarkNtel Advisors Mar 2026

Segment and sub-market figures

AxisSegmentFigureNote
Care setting / payor (qualitative)Public hospitals (MoH network)dominant shareNexdigm: public hospitals hold dominant share
Care setting / payor (qualitative)MoH and public schemes (payor)dominant shareNexdigm: MoH/public schemes dominant payor

Source: As listed under Sources.

Country and regional figures

Country / regionFigureYearSource
Hospitals / beds (MoH annual report, cited by Nexdigm)92 hospitals, 7,691 beds2024Nexdigm
Hospitals / beds (end-2022)90 hospitals (50 MoH), 7,238 beds = 14.7 beds per 10,0002022Oman Observer (MoH)
Healthcare facilities1,592 (2020) to 2,384 (2024), +50%2024Oman Observer (MoH)
Population / expatriates5.30 mn total; 2.25 mn expatriates; 139,649 aged 65+2024Nexdigm
Physician density~2.1 physicians per 1,000 (World Bank)2024Nexdigm
Teleconsultations1.2 mn+ in 2024 (+67% YoY)2024MarkNtel

Source: Sources as named; see Sources and method.

Key facts and context

  • Oman had 92 hospitals and 7,691 beds per the MoH annual report cited by Nexdigm (2025) (Nexdigm)
  • Healthcare facilities rose 50% from 1,592 (2020) to 2,384 (2024); private clinics are 51% of facilities (Oman Observer)
  • Nizwa Hospital expansion (RO 30 mn) adds 245 beds to 555; Sohar Hospital expansion (RO 28 mn) to 636+ beds (Oman Observer)
  • Dhamani platform mandates e-claims and e-eligibility; regulations issued via circular 6521 and Decision E/131/2022 (Nexdigm)
  • NCDs account for ~80-83% of deaths (MoH / WHO) (MarkNtel Advisors)
  • Royal Hospital holds Platinum accreditation from Accreditation Canada; Sultan Qaboos Cancer Centre is JCI accredited (Oman Observer)
  • Vision 2040 target of ~USD 1.59 bn healthcare investment by 2025 cited by MarkNtel (MarkNtel Advisors)
  • Mandatory health insurance for citizens and expatriates has been planned since 2016-17 (originally for 2017 implementation) (LaingBuisson IMTJ)

GCC and India outlook

Where the GCC and India sit

  • Hospitals / beds (MoH annual report, cited by Nexdigm): 92 hospitals, 7,691 beds (2024) — Nexdigm
  • Hospitals / beds (end-2022): 90 hospitals (50 MoH), 7,238 beds = 14.7 beds per 10,000 (2022) — Oman Observer (MoH)
  • Healthcare facilities: 1,592 (2020) to 2,384 (2024), +50% (2024) — Oman Observer (MoH)
  • Population / expatriates: 5.30 mn total; 2.25 mn expatriates; 139,649 aged 65+ (2024) — Nexdigm
  • Physician density: ~2.1 physicians per 1,000 (World Bank) (2024) — Nexdigm
  • Teleconsultations: 1.2 mn+ in 2024 (+67% YoY) (2024) — MarkNtel

Consulting Wallah works this market from both sides: hospital groups in the UAE, Saudi Arabia, India and Bangladesh as buyers, and manufacturers in India, China, Singapore, Malaysia and the US as suppliers through the Network. Our observation is that registration status, in-country stock and structured quotations decide access in the GCC, while price and distributor reach decide it in India. CW observation

Opportunities we see: home healthcare and remote patient monitoring (~20% readmission reduction in rural pilots); telemedicine scale-up (1.2 mn+ teleconsultations in 2024); private hospital capacity in secondary governorates (Dhofar, Batinah, Sharqiyah) as new MoH hospitals open.

Market dynamics

Growth drivers

  • Roll-out of mandatory health insurance (Dhamani platform; e-claims and e-eligibility mandated)
  • Government infrastructure investment: ~RO 1 bn MoH budget 2026; 9 new hospitals adding 1,660+ beds
  • Rising NCD burden: 60%+ adults overweight/obese, ~33% hypertensive, 17% adult diabetes prevalence (IDF 2024)
  • Large expatriate population (2.25 mn) driving private-sector demand
  • PPP models and Vision 2040 push for greater private-sector participation

Restraints

  • Specialist shortages (~2.1 physicians per 1,000) and Omanisation pressures on workforce
  • Referral bottlenecks and capacity concentration in Muscat
  • Import dependence for medicines and devices
  • Reimbursement delays and complex licensing for private operators

Opportunities

  • Home healthcare and remote patient monitoring (~20% readmission reduction in rural pilots)
  • Telemedicine scale-up (1.2 mn+ teleconsultations in 2024)
  • Private hospital capacity in secondary governorates (Dhofar, Batinah, Sharqiyah) as new MoH hospitals open
  • Local pharma manufacturing (USD 39 mn facility at Khazaen Economic City)
  • Insurance-linked growth in private outpatient and diagnostics once Dhamani is fully live

Challenges

  • Regulatory complexity and compliance costs (hospital licence ~USD 7,800; pharma factory licence ~USD 3,900)
  • Slow pace of mandatory insurance enforcement since first announced (planned since 2017)
  • Low forecast growth in some estimates (4.05% CAGR MarkNtel) vs GCC peers
  • Low bed density (14.7 per 10,000) versus demand from ageing and NCDs

Recent developments

DateDevelopmentSource
2026-02MoH 2026 budget ~RO 1 bn; 11+ projects completed (Central Public Health Lab, Khasab Referral Hospital, Al Suwaiq Hospital); 15+ under construction 2026-27; 20+ planned incl. National Centre for Women's and Children's Health in Sultan Haitham CityOman Observer
2026-02Sultan Qaboos Hospital Salalah (700 beds, RO 138 mn, 100,000 sqm) trial opening planned for October 2026Oman Observer
2026-03MarkNtel sizes Oman healthcare market at USD 5.10 bn (2025), forecast USD 6.74 bn by 2032MarkNtel Advisors
2025-07Nexdigm values Oman healthcare market at USD 4.4 bn (2024), 7.5% CAGR to 2030; Dhamani e-linkage regulations formalised by FSANexdigm
20252025 National Survey of NCDs published (hypertension ~33% of adults, dyslipidaemia ~33%)MarkNtel Advisors

Source: Company and press announcements as named.

Competitive landscape

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

Ministry of Health (Royal Hospital, Khoula, Nizwa, Sohar hospitals)Sultan Qaboos University HospitalBadr Al Samaa GroupKIMSHEALTH OmanAster Royal Al Raffah HospitalStarcare HospitalMuscat Private HospitalOman International HospitalBurjeel Hospital OmanAl Hayat International HospitalSultan Qaboos Hospital Salalah (700 beds, opening 2026)Liva Insurance (National Life & General)Dhofar InsuranceAl Madina TakafulOman United InsuranceTakaful OmanOman Qatar Insurance (OQIC)Muscat Pharmacy & Stores (distribution)

What it means for you

  • Operators and investors: capacity, payer rules and licensing timelines decide returns; design central procurement and insurer contracting into the operating model before opening.
  • Suppliers: registration, a local partner and payer-formulary presence are the gates; central tenders reward structured quotations and reliable supply over the lowest price.
  • Hospital leaders: payer pressure makes the 25–35% of cost in supplies the margin lever — see the free executive assessment.

Frequently asked questions

How big is the Oman healthcare market?

Published estimates normalised to 2025 range from USD 4.7 bn to USD 5.1 bn. Consulting Wallah’s central estimate is USD 4.9 bn in 2025, rising to about USD 7.4 bn by 2032.

What is the growth rate?

Published CAGRs range from 4.05% to 7.5%; our central case is about 6% a year to 2032.

Which companies lead?

Ministry of Health (Royal Hospital, Khoula, Nizwa, Sohar hospitals), Sultan Qaboos University Hospital, Badr Al Samaa Group, KIMSHEALTH Oman, Aster Royal Al Raffah Hospital, Starcare Hospital, Muscat Private Hospital, Oman International Hospital among others.

Is the full report free?

The summary on this page is free to read and share with attribution. The full report is free for hospital leaders and registered Consulting Wallah Network members, and priced on request for others.

Sources and method

  1. Nexdigm, Oman Healthcare Market Report — nexdigm.com
  2. MarkNtel Advisors, Oman Healthcare Market Research Report 2026-2032 — marknteladvisors.com
  3. Oman Observer, Strategic health sector projects supported by RO 1 billion budgetary outlay — omanobserver.om
  4. Oman Observer, Health sector witnesses transformation — omanobserver.om
  5. LaingBuisson IMTJ, Mandatory health insurance for Omanis and expatriates — laingbuissonnews.com
  6. Nexdigm (2025-07) — USD 4.4 bn (2024) to — (2030), CAGR 7.5% (2025-2030); scope: country - Oman healthcare market (hospitals, outpatient, payors); public hospitals and MoH/public schemes hold dominant share — source
  7. MarkNtel Advisors (2026-03) — USD 5.10 bn (2026E: USD 5.31 bn) (2025) to USD 6.74 bn (2032), CAGR 4.05% (2026-2032); scope: country - Oman healthcare market (expenditure, pharma, devices, insurance, workforce segments) — source
  8. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
  9. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.

Request the full report

The full report (PDF, 40 pages) adds the GCC and India deep-dives, hospital-level benchmarks from the Consulting Wallah Network and the full source tables. Free for hospital leaders and registered network members; otherwise priced on request.

How to read these figures. Published market-size estimates for this market vary widely because publishers define scope differently (software only vs software + services + logistics). Where we show a Consulting Wallah estimate we state the range of published figures it is triangulated from and our scope. Figures marked as reported are quoted from the named source. Nothing here is investment advice.

Want this applied to your hospital or group?Free executive assessment — spend snapshot, benchmark and opportunity brief. Four slots a month.
Book the assessment